ADAG Adagene Inc.
Healthcare$3.72-0.80%ClosedMarket Cap: $140.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.02
P/S
18.35
EV/EBITDA
-3.49
DCF Value
$-5.52
FCF Yield
-11.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
92.4%
Operating Margin
-279.4%
Net Margin
-229.5%
ROE
-48.2%
ROA
-22.6%
ROIC
-36.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $7.7M | 96.3% | $-5.8M | $-4.1M | $— | — |
| FY null | $7.7M | 100.0% | $-21.4M | $-17.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-15.7M | $-13.5M | $— | — |
| Q4 null | $103.2K | -797.5% | $-26.8M | $-24.9M | $— | — |
| FY null | $103.2K | -797.5% | $-36.0M | $-33.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.2M | $-8.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-9.2M | $-8.5M | $— | — |
| Q4 null | $407.9K | -4.3% | $-9.3M | $-7.4M | $— | — |
| FY null | $18.1M | 100.0% | $-23.7M | $-18.9M | $— | — |
| Q3 null | $407.9K | 100.0% | $-9.3M | $-7.4M | $— | — |
| Q2 null | $8.6M | 0.0% | $-2.5M | $-2.1M | $— | — |
| Q1 2023 | $8.6M | 100.0% | $-2.5M | $-2.1M | $-0.06 | — |